Insitu Vein-bypass is superior to endovascular treatment of femoropopliteal lesions in chronic limb-threatening ischemia.

[1]  Manesh R. Patel,et al.  Corrigendum to 'Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia' [European Journal of Vascular & Endovascular Surgery 58/1S (2019) 1-109]. , 2019, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[2]  P. Kolh,et al.  A systematic review and meta‐analysis of revascularization outcomes of infrainguinal chronic limb‐threatening ischemia , 2018, Journal of vascular surgery.

[3]  A. AbuRahma.  When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease? , 2018, Annals of vascular diseases.

[4]  Jeroen J. Bax,et al.  The 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in Collaboration With the European Society for Vascular Surgery (ESVS). , 2018, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[5]  Jeroen J. Bax,et al.  Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). , 2018, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  Zhen Wang,et al.  Systematic review and meta‐analysis of duplex ultrasound surveillance for infrainguinal vein bypass grafts , 2017, Journal of vascular surgery.

[7]  S. Johansson,et al.  Amputation Rates, Mortality, and Pre-operative Comorbidities in Patients Revascularised for Intermittent Claudication or Critical Limb Ischaemia: A Population Based Study. , 2017, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[8]  M. Schermerhorn,et al.  Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb‐threatening ischemia , 2017, Journal of vascular surgery.

[9]  Maureen A. Smith,et al.  Endovascular Versus Open Revascularization for Peripheral Arterial Disease. , 2017, Annals of surgery.

[10]  S. Assmann,et al.  Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST‐CLI) Trial , 2016, Journal of the American Heart Association.

[11]  A. Dua,et al.  Epidemiology of Peripheral Arterial Disease and Critical Limb Ischemia. , 2016, Techniques in vascular and interventional radiology.

[12]  T. Nishibe,et al.  Endovascular Therapy for Femoropopliteal Artery Disease and Association of Risk Factors With Primary Patency , 2015, Vascular and endovascular surgery.

[13]  J. Hodson,et al.  Factors Affecting the Results of Superficial Femoral Artery Stenting , 2015, Vascular and endovascular surgery.

[14]  L. Norgren,et al.  An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee(.). , 2015, Annals of vascular diseases.

[15]  J. Davaine,et al.  Primary stenting of TASC C and D femoropopliteal lesions: results of the STELLA register at 30 months. , 2014, Annals of vascular surgery.

[16]  G. Tepe,et al.  Standards of Practice for Superficial Femoral and Popliteal Artery Angioplasty and Stenting , 2014, CardioVascular and Interventional Radiology.

[17]  H. Aihara,et al.  Comparison of long-term outcome after endovascular therapy versus bypass surgery in claudication patients with Trans-Atlantic Inter-Society Consensus-II C and D femoropopliteal disease. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[18]  Umair Qazi,et al.  Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease. , 2014, Journal of vascular surgery.

[19]  David G Armstrong,et al.  The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). , 2014, Journal of vascular surgery.

[20]  J. Forbes,et al.  Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. , 2010, Journal of vascular surgery.

[21]  J. Forbes,et al.  Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification. , 2010, Journal of vascular surgery.

[22]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[23]  R. Chaer,et al.  Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions. , 2008, Journal of vascular surgery.

[24]  M. Back,et al.  From the Southern Association for Vascular Surgery Efficacy of duplex ultrasound surveillance after infrainguinal vein bypass may be enhanced by identification of characteristics predictive of graft stenosis development , 2008 .

[25]  John V. White,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[26]  J. Forbes,et al.  Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial , 2005, The Lancet.

[27]  Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Section D: chronic critical limb ischaemia. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.